BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 25897840)

  • 21. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
    Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
    PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-γ/TNF-α ratio in response to immuno proteomically identified human T-cell antigens of Mycobacterium tuberculosis - The most suitable surrogate biomarker for latent TB infection.
    Prabhavathi M; Pathakumari B; Raja A
    J Infect; 2015 Aug; 71(2):238-49. PubMed ID: 25936741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals.
    Abebe F; Belay M; Legesse M; K L M C F; Ottenhoff THM
    PLoS One; 2018; 13(1):e0190989. PubMed ID: 29373577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection.
    Kim K; Perera R; Tan DB; Fernandez S; Seddiki N; Waring J; French MA
    Tuberculosis (Edinb); 2014 Sep; 94(5):494-501. PubMed ID: 25095750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
    Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
    Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
    Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
    Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
    Pathakumari B; Devasundaram S; Maddineni P; Raja A
    Int J Med Microbiol; 2018 Mar; 308(2):297-305. PubMed ID: 29325881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis.
    Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
    J Infect; 2017 Aug; 75(2):132-145. PubMed ID: 28483404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profile of interferon-gamma response to latency-associated and novel in vivo expressed antigens in a cohort of subjects recently exposed to Mycobacterium tuberculosis.
    Araujo LS; da Silva NBM; da Silva RJ; Leung JAM; Mello FCQ; Saad MHF
    Tuberculosis (Edinb); 2015 Dec; 95(6):751-757. PubMed ID: 26421415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.
    Sahiratmadja E; Alisjahbana B; de Boer T; Adnan I; Maya A; Danusantoso H; Nelwan RH; Marzuki S; van der Meer JW; van Crevel R; van de Vosse E; Ottenhoff TH
    Infect Immun; 2007 Feb; 75(2):820-9. PubMed ID: 17145950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific cytokine patterns of pulmonary tuberculosis in Central Africa.
    Nemeth J; Winkler HM; Boeck L; Adegnika AA; Clement E; Mve TM; Kremsner PG; Winkler S
    Clin Immunol; 2011 Jan; 138(1):50-9. PubMed ID: 20951096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7.
    Kim SY; Park MS; Kim YS; Kim SK; Chang J; Lee HJ; Cho SN; Kang YA
    Scand J Immunol; 2012 Dec; 76(6):580-6. PubMed ID: 22946827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QuantiFERON-TB Gold In-Tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study.
    Belay M; Legesse M; Dagne D; Mihret A; Bekele Y; Medhin G; Bjune G; Abebe F
    BMC Infect Dis; 2014 Dec; 14():654. PubMed ID: 25466365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area.
    Silva LC; Silveira GG; Arnone M; Romiti R; Geluk A; Franken KC; Duarte AJ; Takahashi MD; Benard G
    Arch Dermatol Res; 2010 May; 302(4):255-62. PubMed ID: 19609541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential activation of innate and adaptive lymphocytes during latent or active infection with Mycobacterium tuberculosis.
    Ruiz-Sánchez BP; Castañeda-Casimiro J; Cabrera-Rivera GL; Brito-Arriola OM; Cruz-Zárate D; García-Paredes VG; Casillas-Suárez C; Serafín-López J; Chacón-Salinas R; Estrada-Parra S; Escobar-Gutiérrez A; Estrada-García I; Hernández-Solis A; Wong-Baeza I
    Microbiol Immunol; 2022 Oct; 66(10):477-490. PubMed ID: 35856253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis.
    Higuchi K; Harada N; Fukazawa K; Mori T
    Tuberculosis (Edinb); 2008 May; 88(3):244-8. PubMed ID: 18294915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.
    Hur YG; Gorak-Stolinska P; Ben-Smith A; Lalor MK; Chaguluka S; Dacombe R; Doherty TM; Ottenhoff TH; Dockrell HM; Crampin AC
    PLoS One; 2013; 8(11):e79742. PubMed ID: 24260295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
    Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H
    J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.